tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (CH:NWRN)
:NWRN
Switzerland Market

Newron Pharmaceuticals SpA (NWRN) Income Statement

Compare
0 Followers

Newron Pharmaceuticals SpA Income Statement

Last quarter (Q4 2024), Newron Pharmaceuticals SpA's total revenue was €47.98M, an increase of 1370.07% from the same quarter last year. In Q4, Newron Pharmaceuticals SpA's net income was €25.40M. See Newron Pharmaceuticals SpA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 51.39M€ 9.06M€ 6.09M€ 5.76M€ 5.26M
Gross Profit
€ 51.39M€ 9.06M€ 6.09M€ 5.76M€ 4.96M
Operating Expenses
€ 25.22M€ 20.69M€ 19.68M€ 17.78M€ 22.70M
Depreciation and Amortization
€ 192.00K€ 201.00K€ 202.00K€ 209.00K€ 219.00K
EBITDA
€ 25.94M€ -11.83M€ -13.32M€ -12.31M€ -17.99M
Operating Income
€ 26.17M€ -11.63M€ -13.30M€ -12.36M€ -18.07M
Other Income/Expenses
€ -4.78M€ -4.57M€ -4.17M€ -2.53M€ -1.55M
Pretax Income
€ 21.39M€ -16.20M€ -17.47M€ -14.88M€ -19.62M
Net Income
€ 15.84M€ -16.22M€ -17.49M€ -14.90M€ -21.00M
Per Share Metrics
Basic EPS
€ 0.85€ -0.91€ -0.98€ -0.84€ -1.18
Diluted EPS
€ 0.85€ -0.91€ -0.98€ -0.84€ -1.18
Weighted Average Shares Outstanding
18.56M 17.84M 17.84M 17.84M 17.84M
Weighted Average Shares Outstanding (Diluted)
18.56M 17.84M 17.84M 17.84M 17.84M
Currency in EUR

Newron Pharmaceuticals SpA Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis